CARDIOL THERAPEUTICS INC. (CRDL)
Clinical trial NCT02699957 updates: 1. completion date: 2026-01-01 → 2029-01-01 2. primary completion date: 2026-01-01 → 2029-01-01
Clinical trial NCT02699957 updates: 1. completion date: 2026-01-01 → 2029-01-01 2. primary completion date: 2026-01-01 → 2029-01-01
Clinical trial NCT00148837 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: not set → 2008-12-01 3. primary completion date: not set → 2008-12-01 4. collaborators added: Pfizer
Clinical trial NCT06549348 updates: 1. completion date: 2026-06-30 → 2027-06-30 2. primary completion date: 2026-06-30 → 2027-06-30
Clinical trial NCT06510205: enrollment: 5000 → 6111 participants.
Clinical trial NCT07597928 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-12 → 2026-05-13
Clinical trial NCT07013643 updates: 1. completion date: 2026-12-25 → 2027-07-09 2. primary completion date: 2026-12-25 → 2027-07-09
Clinical trial NCT06380179 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2026-03-02 3. primary completion date: 2025-12-01 → 2026-03-02 4. enrollment: 116 → 29 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: Uniformed Services University of the Health Sciences 7. collaborators removed: Uniformed Services University …
Deadline Approaching: Via Transportation, Inc. (VIA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Payoneer Global Inc. (NASDAQ: PAYO)
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Roku, Inc. (NASDAQ: ROKU)